AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimigrand-M2 Tablet SR

Prescription Icon
Prescription Required

Marketer

D Earth Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimigrand-M2 Tablet SR

DiaBeta-Duo SR tablets are antidiabetic medications combining two agents to manage type 2 diabetes in adults. They help regulate blood glucose. DiaBeta-Duo SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a holistic approach including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may occur. DiaBeta-Duo SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Consult your doctor before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are advised by your physician.

Primary Ingredients of Glimigrand-M2 Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimigrand-M2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimigrand-M2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimigrand-M2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Glimigrand-M2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigrand-M2 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimigrand-M2 Tablet SR should be administered with a meal.

How Glimigrand-M2 Tablet SR works:

Glimigrand-M2 SR tablets contain a dual-action antidiabetic formula comprised of glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimigrand-M2 Tablet SR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigrand-M2 Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimigrand-M2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity associated with the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimigrand-M2 Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimigrand-M2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimigrand-M2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimigrand-M2 Tablet SR :

Should you forget a dose of Glimigrand-M2 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigrand-M2 Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimigrand-M2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimigrand-M2 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimigrand-M2 Tablet SR and seek immediate medical attention.
Glimigrand-M2 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glimigrand-M2 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimigrand-M2 Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (including tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimigrand-M2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimigrand-M2 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimigrand-M2 Tablet SR
110
MRP 134
17% off